Survivin has been investigated in various other cancers, such as pancreatic, adenocarcinoma, esophageal cancers, bladder and breast cancers; these studies have predominantly determined the mRNA expression levels in the cells, and found the expression levels of Survivin mRNA to be significantly elevated. This evidence concerns the gene BIRC5 and breast cancer.